Sort
1,049,261 grants matching “t cell”
A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION
$1,984,084Laurie Sower · Chrysalis Biotherapeutics, Inc. · N01 · FY2018 · AI
HiTIF Microscopy Core Facility
$1,984,068Gianluca Pegoraro · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Genetic Approaches to Cancer Immunotherapy
$1,984,035Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Center of Biomedical Research
$1,984,013Julia T Oxford · Boise State University · P20 · FY2017 · GM
Structure-Based Antagonism of HIV-1 Envelope Function in Cell Entry
$1,983,930Irwin M Chaiken · Drexel University · P01 · FY2018 · GM
Peptide-Protein Conjugate Vaccines
$1,983,871Rachel Schneerson · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Co-designing Ethical Multimodal AI Systems for Mapping T1D Progression
$1,983,847Jie Liu · University Of Michigan At Ann Arbor · OT2 · FY2025 · OD
Cell and molecular pathobiology of Alzheimer's Disease
$1,983,838Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2009 · AG
Interactions of Lymphocytes, Cytokines and Airway Cells
$1,983,807University Of California San Francisco · P50 · FY2005 · HL
Adaptation to Hypoxia
$1,983,726Kurt R Stenmark · University Of Colorado Denver · P01 · FY2016 · HL
TRANSCRIPTIONAL REGULATION OF CELL GROWTH
$1,983,606Salk Institute For Biological Studies · P01 · FY2000 · CA
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
$1,983,570Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U24 · FY2023 · CA
A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty
$1,983,531Anthony Andrew Oliva · Longeveron, Llc · R44 · FY2019 · AG
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)
$1,983,520Thomas L Vaughan · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies
$1,983,517Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2012 · AI
High Performance Computing for Biomedical Research
$1,983,480Michael J Levine · Carnegie-Mellon University · P41 · FY2010 · RR
Systematically mapping variant effects for cardiovascular genes
$1,983,411Dan M Roden · Vanderbilt University Medical Center · R01 · FY2024 · HL
Impact of FGF21 on healthspan and lifespan
$1,983,293Vishwa Deep Dixit · Yale University · P01 · FY2020 · AG
Developmental origins of mental illness: evolution and reversibility
$1,983,261Takao K Hensch · Harvard University · P50 · FY2021 · MH
Developmental origins of mental illness: evolution and reversibility
$1,983,261Takao K Hensch · Harvard University · P50 · FY2020 · MH
Developmental origins of mental illness: evolution and reversibility
$1,983,261Takao K Hensch · Harvard University · P50 · FY2019 · MH
Developmental origins of mental illness: evolution and reversibility
$1,983,261Takao K Hensch · Harvard University · P50 · FY2022 · MH
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$1,983,212Steven Jacobson · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
MOLECULAR-NUTRIENT INTERACTIONS IN INTESTINAL CANCER
$1,983,087Montefiore Medical Center (Bronx, Ny) · U54 · FY2005 · CA
Molecular Genetics of Fanconi Anemia
$1,983,074Robb E Moses · Oregon Health & Science University · P01 · FY2006 · HL